Skip to main content
Shockwave Medical looks to raise $70M in IPO

A preliminary prospectus has been filed by Shockwave Medical for an initial public offering that could bring in $70 million. The firm develops products to treat calcified cardiovascular disease through a process called intravascular lithotripsy, and its Shockwave M5 IVL catheter was cleared by European and US regulators last year.

Full Story: